Hims is one of the many platforms that offer telehealth online from licensed providers, with services spanning from skincare and hair loss to anxiety and erectile dysfunction. In this review, we ...

Hims & Hers' strong Q3 results and 77% y/y revenue growth demonstrate its robust business, justifying a continued strong buy ...

Viagra and its generic version, sildenafil, require a prescription. Follow along as a tester goes through our picks to get an idea of the smoothest online process. Hims Hard Mints are a discreet ...

Popular products the company sells include hair loss treatment, ED medication and more recently weight-loss drugs made from GLP-1. What I really like about HIMS value proposition is that it has ...

If you struggle with ED, drugs like Viagra®, sildenafil, tadalafil, and other FDA-approved medications could help with your ...

Learn more about Hims. Ro, formerly Roman, offers various treatment options for conditions such as ED, hair loss, and premature ejaculation. Generic sildenafil starts from $4 per dose ...

Hims & Hers (NYSE: HIMS) fell as much as 12% in trading on Wednesday after pharmaceutical company Novo Nordisk (NYSE: NVO) asked the FDA to not allow companies to compound GLP-1 semaglutide. This ...

What Is Erectile Dysfunction (ED)? Erectile dysfunction—defined as difficulty in getting or maintaining an erection firm enough for sex—is a very common issue. Overall, research suggests as ...

Hims & Hers Health Inc. said an analysis of more than 10,000 patients taking a copycat version of Novo Nordisk A/S’s Ozempic and Wegovy showed the shot was a safe and effective way to shed pounds.

Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term ...

Allen Lutz, an analyst from Bank of America Securities, maintained the Buy rating on Hims & Hers Health (HIMS – Research Report). The associated price target remains the same with $25.00.